CD7-targeted CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD7-targeted CAR T cells, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies [NA]